Trials / Sponsors / Calico Life Sciences LLC
Calico Life Sciences LLC
Industry · 7 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration Healthy Volunteer | Phase 1 | 2024-05-21 |
| Completed | A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects Healthy | Phase 1 | 2024-03-14 |
| Completed | A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262 Healthy | Phase 1 | 2023-12-19 |
| Completed | A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects Healthy | Phase 1 | 2023-03-24 |
| Recruiting | An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease Vanishing White Matter Disease | Phase 1 / Phase 2 | 2023-03-13 |
| Recruiting | Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors Advanced Solid Tumor Cancer | Phase 1 | 2021-03-09 |
| Available | Expanded Access to ABBV-CLS-484 Advanced Solid Tumor Cancer | — | — |